Dr. Anupama Raghuram discusses OIs in HIV by first reviewing pathogenesis, clinical manifestations, diagnosis, and select opportunistic infections in HIV positive patients. She then discusses challenges in diagnosis and treatment options for select OIs in HIV positive patients
In Controlling Multi-Drug Resistant Bacteria in the Healthcare Setting: The Role of the Hospital Epidemiologist with Dr. Forest W. Arnold, Dr. Arnold covers the MDR control program as well as strategies to prevent and manage MDR.
Dr. Raghuram presents and reviews the main classes of HIV medications and their mechanisms of action. She the explains the principles of HIV combination therapy and discusses some of the main side effects of the most commonly used HIV medications.
In this lecture Dr. Raghuram takes a look at traditional and new definitions of FUOs as well as a practical algorithm for their workup. She takes a comprehensive look at common non-infectious causes including often used drugs that can produce fevers in patients. Dr. Raghuram finishes with several cases presented in a board review style and walks through her thought process with evaluating the questions.
Dr. Raghuram review common rickettsial diseases (Rocky Mountain Spotted Fever, Typhus, Mediterranean Spotted Fever, African Tick Bite Fever, and less common species) with a focus on board review. She delves into geography, vectors and pathophysiology of these diseases as well as discussing common look-a-like diseases.
In this illuminating Grand Rounds lecture, Dr. Rahel Bosson and Ruth Carrico give an overview of the real struggle of the refugee population and provide an update of the current state of refugee health in Kentucky. They give an overview of the Global Health Initiative at University of Louisville which includes the follow programs: HIV/AIDs, Refugee Health and Immunization, Vaccine and International Travel and Global Health Research Support. The talk concludes looking to the future with a comprehensive Global Health Center composed of improving refugee orientation and EMR, healthcare worker education, developing guidelines and bettering our surveillance and epidemiology surrounding global health populations.
Dr. Kris Krueger reviews the epidemiology and pathogenesis of C.difficile in the U.S. Then, she gives an update on current medical treatments including antibiotic, probiotic and surgical treatment before covering the evidence behind fecal microbial transplant. She also addresses prevention strategies and emerging C.difficile therapies such as immunotherapy and vaccines.
Dr. Martin Gnoni presents on urinary tract infections using the Infectious Disease Society of America's guidelines. He covers acute, uncomplicated cystitis and pyelonephritis in both pregnant and non-pregnant women. He then discusses complicated UTIs including those in men. Finally, he addresses catheter associated UTIs
Julie Harting covers penicillins and cephalosporins including cases, adverse reactions, and other considerations.